Dr. Celine Marquez  is the radiation oncology lead for QoL, molecular biologist, and a UCSF  Clinical Innovation Fellow with expertise in electronic patient reported  outcomes (PROs) and radiogenomics. She is interested in advancing the use of  real-time electronic PROs to monitor quality and the use of PRO data for  machine learning to predict adverse events and outcomes based on genomic and  proteomic data.